ISSN 2409-5834

Development of a Self-Microemulsifying Solid Dosage Formulation for Enhanced Solubility and Stability of Meloxicam: A Comprehensive Study

Main Article Content

Saja Abdulkareem Muhammed ,Khalid Kadhem Al-Kinani


Meloxicam (MLX), a nonsteroidal anti-inflammatory drug belonging to the oxicam family, is commonly used to alleviate inflammation and pain. However, MLX's limited solubility and subsequent low bioavailability necessitate the development of innovative formulations. This study aimed to improve the dispersibility and stability of MLX by incorporating it into a self-microemulsifying liquid drug delivery system (SMLDDS) and subsequently converting it into a solid dosage form, specifically capsules

Article Details